Lupin Pharmaceuticals, Inc., a prominent player in the global pharmaceutical industry, is headquartered in the United States. Founded in 1968, the company has established a strong presence in various operational regions, including North America, Europe, and Asia. Specialising in generic and branded medications, Lupin focuses on therapeutic areas such as cardiovascular, diabetes, and central nervous system disorders. With a commitment to innovation, Lupin has achieved significant milestones, including numerous FDA approvals and a robust pipeline of products. Their core offerings, which include high-quality generics and specialty pharmaceuticals, are distinguished by their efficacy and affordability. As a leading manufacturer, Lupin Pharmaceuticals is recognised for its market position, consistently ranking among the top generic drug producers in the US, reflecting its dedication to improving patient outcomes worldwide.
We don't have data for Lupin Pharmaceuticals, Inc., but we can show you information about their parent organization instead.
View parent company